Palbociclib, also known as Ibrance, targets weaknesses in cancer to stop cells dividing and spreading - delaying the need for chemotherapy adding years to the lives of women with the disease.
from Articles | Mail Online https://ift.tt/2Ruyyg9
- Blogger Comment
- Facebook Comment
Subscribe to:
Post Comments
(
Atom
)
0 comments:
Post a Comment